Investor Relations
Partnerships are integral to Harbour BioMed's strategy to build a fully integrated biopharmaceutical company.
-
Dec 08, 2021
2021 R&D Day
-
Sep 14, 2021
HBM4003 Phase I Data Readout
-
Aug 31, 2021
2021 Interim Results Conference Call
-
Jul 07, 2021
HBM9161 MG Phase II Trial Topline Data Readout
-
Jun 17, 2021
2021 Investors Forum
Copyright © 2022 Harbour BioMed. All Rights Reserved 沪ICP备19015946号-1